Luca Bertero

Associate professor of Pathology

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Luca Bertero is an Associate Professor of Pathology at the University of Turin, Italy. His research areas include tumor immune microenvironments, treatment-refractory meningiomas, and the molecular profiling of various cancers, particularly in relation to targeted therapies and immunotherapy. Recent articles authored by Professor Bertero focus on the clinical implications of tumor biology in conditions such as ovarian carcinoma and breast cancer.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (21)

Kåre Fugleholm

Københavns Universitet

DENMARK

Luca Bertero

Research Interests

Explore related searches

Contact this professor

About

Articles (27)

European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection

Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review

STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome

The concept, intention, and evaluation of the term treatment-refractory meningioma

Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in Immunotherapy

Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)

The role of meningioma integrated molecular profiling to improve patient management and disclose novel therapeutic targets

The importance of considering competing risks in recurrence analysis of intracranial meningioma

Differentiated vulvar intraepithelial neoplasia long‐term follow up and prognostic factors: An analysis of a large historical cohort

Understanding and Managing Pineal Parenchymal Tumors of Intermediate Differentiation: An In-Depth Exploration from Pathology to Adjuvant Therapies

Ancient schwannoma of the anterior mandibular vestibule: A rare case reported and literature review

Comedo-like growth pattern in invasive early-stage cervical cancer: A new feature related to parametrial involvement

Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2 -Mutant Lower-Grade Glioma

Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update

The early recognition and diagnosis of neoplastic meningitis

Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications

Growth Hormone-Secreting Pituitary Adenoma: Dura Mater Invasion Is Not a Predictor of Acromegaly Persistence After Trans-Sphenoidal Surgery

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline

Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches

Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

Spinal epidural capillary hemangioma: case report and review of the literature

Low PD‐L1 expression in immune cells predicts the presence of nodal metastasis in early invasive (pT1) colorectal cancer: a novel tool to tailor surgical treatment

COVID-19 and Breast Cancer: Analysis of Surgical Management of a Large Referral Center during the 2020–2021 Pandemic Period

Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer

FISH Diagnostic Assessment of MDM2 Amplification in Liposarcoma: Potential Pitfalls and Troubleshooting Recommendations

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

Collaborators (21)

Kåre Fugleholm

Pieter Wesseling

Giovanna Mantovani

Andrea Roberto Carosso

Monika Hegi

Gianluca Witel

Alessandro Gambella

Pim French

Francesco Bruno

Daniela Bota

Fabio Bioletto

Enrico Berrino

JESSICA CUSATO

Bastiaan Tops

Paola Cassoni

Luca Marozio

Mario PRETI

Bjarne Winther Kristensen

Felix Sahm

Diego Garbossa

Torstein R. Meling

Make your next move.